Ester Schallinger

Ester Schallinger: Email & Phone Number

Opt-Out
Regulatory Affairs Associate at Dexcel Pharma|Israel

Position:

Regulatory Affairs Associate at Dexcel Pharma

Location:

Israel

LinkedIn
View Ester Schallinger's Email
Up to 10 free lookups. No credit card required.
Last updated: 2026-05-08
Updated: 2026-05-08

Found email addresses for Ester Schallinger:

Business emails:

Found phone for Ester Schallinger:

Searching for Ester Schallinger profiles
0% completed

A different Ester Schallinger?

Sign up to search for other Ester Schallinger's across our 850M+ professionals database

Work Experience 20 years

Regulatory Affairs Associate at Dexcel Pharma

Jun 2023 - Current

Team Leader - Method development and validation at Pluri

Sep 2020 - Nov 2022

Lead Scientist- method development and validation at Pluri

Jan 2016 - Sep 2020

Senior Microbiologist at Taro Pharmaceuticals

Jan 2015 - Jan 2016

Scientist at Public Health England

Jan 2011 - Jan 2015

Research Assistant at ProImmune

Jan 2010 - Jan 2011

Teaching Assistant at University of Haifa

Jan 2007 - Jan 2010

R&D Incentives Consultant at EY

Jan 2006 - Jan 2007

Ester Schallinger started working in 2006, then the employee has changed 6 companies and 7 jobs. On average, Ester Schallinger works for one company for 2 years 6 months.

Their professional focus is Analytical Skills, Assay Development, and Assay validation across 3 core areas.

Education

Bachelor’s Degree at Technion - Israel Institute of Technology

Master’s Degree at University of Haifa

Frequently Asked Questions

SignalHire found a verified business email address for Ester Schallinger: s***************r@dexcel.com.
SignalHire found a verified phone number for Ester Schallinger: +972-***-***-8623.
You can reach Ester Schallinger through SignalHire by unlocking their verified email and direct phone number (free signup, no credit card needed). SignalHire is the fastest route if you need their contact details immediately.
Ester Schallinger has 20 years of professional experience. They have held roles including Team Leader - Method development and validation, Lead Scientist- method development and validation, and Senior Microbiologist at companies such as Pluri, Pluri, and Taro Pharmaceuticals. Their education includes Bachelor’s Degree from Technion - Israel Institute of Technology, and Master’s Degree from University of Haifa.
Yes. Ester Schallinger's SignalHire profile was last updated on 8 May 2026, reflecting their current position as Regulatory Affairs Associate at Dexcel Pharma in Or Akiva, Or Akiva, Israel.

Similar profiles

Name
Company
Position
Kamalesh Chinnathambi
Regulatory Affairs Associate
Get contacts
Sneha Patil
Regulatory Affairs Associate
Get contacts
Zhiyu Hu
Regulatory Affairs Associate
Get contacts
Sai Shree Kunadharaju
Regulatory Affairs Associate
Get contacts
Mina Cho
PharmaResearch Bio Co. Ltd.
Regulatory Affairs Associate
Get contacts
Nikita Dabhade
Regulatory Affairs Associate
Get contacts
See more profiles

Other employees at Dexcel Pharma

Name
Company
Position
Adi Pistiner
Programing and Logistic Laboratories Manager
Get contacts
Efraim Rajman
Farmaceutico responsable
Get contacts
Johanna Bensoussan
Validation Engineer
Get contacts
Sigal Blau
Head of R&D CMC department, Jerusalem
Get contacts
Asi Davidovich
Site Manager
Get contacts
Nagham Marei
Analyst
Get contacts
Esther Lukasiewicz Hagai
Chief Medical Officer & Head of Innovative Development
Get contacts
Amit Rotem
VP Human Resources
Get contacts
Diana Avdeev
QC Analyst
Get contacts
Iulia Alieksieieva
QC Analyst/Analytical Chemist
Get contacts
See more profiles

Data Privacy

GDPR Icon

GDPR COMPLIANT

SignalHire complies with the General Data Protection Regulation (GDPR). SignalHire follows GDPR requirements, including but not limited to rights of data subjects to access, correct, or delete their personal information and supports the right to be forgotten.

CCPA Icon

CCPA COMPLIANT

SignalHire is CCPA-compliant and provides California residents the right to know, access, opt out, and request deletion of their personal data.

BACK TO TOP